Skip to main content

Table 2 Presence of laboratory-confirmed virus

From: Self-medication and ILI etiologies among individuals presenting at pharmacies with influenza-like illness: Guatemala City, 2018 influenza season

 

n = 130

%

Influenza A

38

29% (38/130)

Influenza A (H3N2)

22

58% (22/38)

Influenza A (H1N1pdm09)

13

34% (13/38)

Influenza A (H3N2 + RSV)

1

3% (1/38)

Influenza A (H3N2 + Adenovirus)

1

3%(1/38)

Influenza A (H3N2 + Parainfluenza III)

1

3%(1/38)

Positive viral result, other than Influenza A

17

13%(17/130)

Parainfluenza III

6

35%(6/17)

Parainfluenza I

4

24%(4/17)

Parainfluenza II

3

18%(3/17)

Adenovirus

2

12%(2/17)

Human metapneumovirus

1

6%(1/17)

Negative viral result

75

58% (75/130)

  1. Note The proportion of confirmed cases for influenza A during the peak flu season in Central America confirmed a relatively high prevalence of influenza A. Nasal and oropharyngeal swabs were tested by singleplex rRT-PCR according to US Centers for Disease Control and Prevention protocols for respiratory syncytial virus (RSV), parainfluenza viruses (PIV) 1–3, adenovirus, human metapneumoviruses (hMPV), rhinoviruses, and influenza viruses, including influenza A/H1N1pdm09, A/H3N2, and B (Morgan et al., 2013; Pan American Health Organization, 2011)
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us